Nina Shah
Financials Analyst
Articles 755
Takeda Projects Slight Revenue Downturn but Enhances Profit Estimates for 2025 on Cost Efficiencies
Pharmaceutical giant Takeda navigates Vyvanse revenue pressure amid robust cost control and operational improvements
Takeda Pharmaceutical Company Limited reported third-quarter adjusted net income of 235 billion yen ($1.53 billion), marking a year-over-year increase...
Washington Post Reporters Appeal to Jeff Bezos Against Proposed Newsroom Layoffs
Staff Warns That Reductions Could Undermine The Paper’s Diverse Coverage and Subscriber Growth
Amid anticipated layoffs at The Washington Post, various reporter teams have written directly to owner Jeff Bezos pleading to preserve newsroom divers...
Tesla's Emerging Robotaxi Model Could Shift Vehicle Ownership Economics
Elon Musk outlines a vision where Tesla owners may generate income by lending cars to an autonomous network
Tesla CEO Elon Musk presented a vision during the company’s recent earnings call that could change the financial dynamics of Tesla ownership. He des...
Xerox Faces Profit Decline Amid Rising Memory Costs and Revenue Miss
Despite top-line growth, Xerox’s margins and earnings fall short as integration efforts progress
Xerox Holdings Corp. reported fourth-quarter fiscal results showing robust revenue growth but missed analyst estimates, weighed down by escalating mem...
UnitedHealth: Defensive Long After the Medicare Shock - Trade Plan with Entries, Stops and Targets
Buy the market leader in a beaten sector — tactical position with clear risk controls as Medicare noise settles
UnitedHealth (UNH) has been punished on policy headlines and Q4 noise, but the company’s scale, cash flow and Optum franchise give it room to absorb...
Sanofi Signals Challenges in Replacing Dupixent as Patent Expiry Nears
Q4 Sales Beat Currency-Adjusted Expectations; Growth to Continue Despite Dupixent Exclusivity Loss
Sanofi SA disclosed fourth-quarter financial results showcasing robust growth fueled by flagship drug Dupixent and new pharmaceutical launches. Despit...
AerCap 2026: Still Room to Run — Buy on Strength, Prefer a Pullback Entry
Aircraft-leasing momentum, dividend lift and durable recovery in demand underpin a selective long; manage rate and residual-value risk with disciplined stops.
AerCap (AER) has run hard over the past year but fundamentals still support upside: global fleet demand, improving lease rates for narrowbodies, and a...
Understanding Spousal Social Security Benefits: Essential Insights for Retired Couples
A detailed guide on how spousal benefits work, eligibility, and claiming strategies under Social Security
Social Security benefits differ based on individual earnings histories, but spousal benefits offer crucial support for those with lower or non-traditi...
Healthcare Triangle Sees After-Hours Stock Surge Following Strategic Acquisition
HCTI's purchase of Spanish entities Teyamé 360 and Datono Mediación signals expansion amid prolonged share price weakness
Healthcare Triangle Inc. experienced a substantial after-hours stock increase of over 34% post-announcement of a completed acquisition. The company fi...
Gold Hits Unprecedented Highs as Equity Markets Show Relative Weakness
Peter Schiff Labels Current Market Conditions a 'Historic Bear Market' Amid Record Gold Gains
Economist Peter Schiff signals a historic bear market for U.S. equities, highlighting gold's largest one-day dollar increase ever and a marked decline...